Just a couple of possibilities:
AFR article (Smart Money) talks about CSL being reagrded as cyclical and that it will recover. It is also paying out 40% of profit as a dividend this half.
Another possibility is that its proposed aquisition (is it Aventis blood products I can't rememeber) which was unpopular with the market and led toa significant fall in sp, could perhaps be off. Just speculating.
H
why up?, page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.66 |
Change
1.790(0.60%) |
Mkt cap ! $146.0B | |||
| Open | High | Low | Value | Volume |
| $301.73 | $302.12 | $299.87 | $209.3M | 694.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1810 | $301.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.75 | 780 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |